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In Brief
IRE1, an endoplasmic reticulum (ER) ki-
nase/RNase, splices XBP1/HAC1 to pro-
duce an active transcription factor but
also cleaves ER-associated mRNA
through regulated IRE1-dependent decay
(RIDD). Using biochemical studies, Tam
et al. demonstrate that cleavage of
XBP1 and HAC1 and RIDD are distinct
and separable activities. Cooperative ac-
tion of IRE1 subunits within the oligomer
is required for maximum XBP1/HAC1
splicing activity. In contrast, RIDD does
not require such cooperativity or oligomer
formation. Additionally, selective activa-
tion of RIDD results in cell death.
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An evolutionarily conserved unfolded protein
response (UPR) component, IRE1, cleaves XBP1/
HAC1 introns in order to generate spliced mRNAs
that are translated into potent transcription factors.
IRE1 also cleaves endoplasmic-reticulum-associ-
ated RNAs leading to their decay, an activity termed
regulated IRE1-dependent decay (RIDD); however,
the mechanism by which IRE1 differentiates intron
cleavage from RIDD is not well understood. Using
in vitro experiments, we found that IRE1 has two
different modes of action: XBP1/HAC1 is cleaved
by IRE1 subunits acting cooperatively within IRE1
oligomers, whereas a single subunit of IRE1 performs
RIDD without cooperativity. Furthermore, these
distinct activities can be separated by complementa-
tion of catalytically inactive IRE1 RNase and muta-
tions at oligomerization interfaces. Using an IRE1
RNase inhibitor, STF-083010, selective inhibition of
XBP1 splicing indicates that XBP1 promotes cell sur-
vival, whereas RIDD leads to cell death, revealing
modulation of IRE1 activities as a drug-development
strategy.
INTRODUCTION AND RESULTS
IRE1 is a transmembrane receptor kinase located on the surface
of the endoplasmic reticulum (ER) that initiates the unfolded
protein response (UPR) pathway and is required for the ER
to function properly. Upon activation, IRE1 becomes an active
endoribonuclease (RNase) that cleaves an intron of an mRNA
coding for a bZIP transcription factor, HAC1 in yeast or XBP1
in mammalian cells (Calfon et al., 2002; Gonzalez et al., 1999;
Kawahara et al., 1997; Sidrauski and Walter, 1997). Cleaved
exons are then ligated by tRNA ligase in the case ofHAC1 (Sidur-
aski et al., 1996) and RtcB for XBP1 (Lu et al., 2014) generating
the spliced form of HAC1 or XBP1 mRNA. The IRE1-dependent
splicing step is critical for mounting the UPR, as only the spliced
form of HAC1 or XBP1 mRNA produces a potent transcription
factor that induces UPR gene expression needed for re-estab-
lishment of ER functions.850 Cell Reports 9, 850–858, November 6, 2014 ª2014 The AuthorsRecently, UPR-activated IRE1 in several organisms—
including S. pombe, mammalian, Drosophila, and plant cells—
has been reported to also cleave a subset of mRNA that is asso-
ciated with the ER membrane (Han et al., 2009; Hollien et al.,
2009; Hollien and Weissman, 2006; Kimmig et al., 2012; Mishiba
et al., 2013) In these cases, however, IRE1-mediated cleavage is
followed by degradation, a process that has been termed regu-
lated IRE1-dependent decay (RIDD) (Hollien et al., 2009). At pre-
sent, a detailed, mechanistic understanding of IRE1 engaged in
either RIDD or XBP1mRNA intron cleavage is lacking. IRE1 that
cleaves the XBP1 intron must be coordinated with a ligase to
generate the spliced form of XBP1. In contrast, IRE1 engaged
in RIDDmust be coupled with mRNA degradation enzymes in or-
der to prevent either translating or ligating cleavage products.
Curiously, RIDD has never been reported to occur in the budding
yeast, S. cerevisiae.
To investigate the mechanistic relationship between XBP1/
HAC1 splicing and RIDD, we first asked if IRE1 from the
budding yeast S. cerevisiae can perform RIDD cleavage events.
After treating cells with tunicamycin (Tm), a well-characterized
inducer of UPR, levels of two mRNAs, DAP2 (DPAPB) and
MFa1 (a-Factor) coding for secretory pathway proteins (Fig-
ure S1A), decreased in agreement with genome-wide tran-
scription analyses (Gasch et al., 2000; Travers et al., 2000).
The decrease in mRNA levels required IRE1 but not HAC1 (Fig-
ure S1A) and was well correlated with the kinetics of HAC1
splicing (Figure S1B). Using an in vitro RNase assay, recombi-
nant yeast IRE1 (yIre1) can cleave HAC1 RNA (Figure S1C) and
in vitro transcribed radiolabeled DAP2 (Figure 1A) and MFa1
(Figure S1D) RNA upon incubation with ADP. The RNA cleav-
age fragments generated by yIre1 cleaving mammalian mRNAs
that are known substrates for RIDD such as BLOS1 or INSULIN
were essentially identical to those generated by human recom-
binant IRE1 (hIre1) (compare Figures 1A and 1B). Notably,
recombinant yeast and human Ire1 did not cleave the mRNA
of ACTIN, a nonsecretory protein, demonstrating that Ire1 is
not a random nonspecific RNase (Figure S1C). Furthermore,
mutating the invariant guanosine (Gonzalez et al., 1999; Han
et al., 2009; Kawahara et al., 1997) located at the RIDD
cleavage site of the INSULIN mRNA abolished cleavage at
that site and instead generated aberrantly cleaved fragments
(Figure S1E), reminiscent of other RNA processing events
(Yang, 2011). These results demonstrate that RIDD activity is
conserved in yIre1.
Figure 1. In Vitro Cleavage of RIDD Sub-
strate RNA Is Distinct from XBP1/HAC1
Cleavage
(A and B) In vitro cleavage of RIDD. In vitro
transcribed radiolabeled mammalian (BLOS1,
INSULIN) and yeast (DAP2) RNA substrates
(0.5 nM) were incubated with ADP (2mM) and 1 mM
recombinant WT yIre1 (A) or WT hIre1 (B) for up to
30 min. Black arrow, full-length RNA; gray arrow,
cleaved RNA fragments.
(C and D) Using single-turnover conditions (Fig-
ure S1F), HAC1 RNA cleavage reactions were
competed by excess unlabeled (cold) HAC1 or
XBP1 RNA (15 mM) but not with RIDD RNA (15 mM).
Reactions were performed with 2 mM ADP for up
to 10 min. (C) kobs calculated from these reactions
are shown in (D). Error bars of all the experiments in
this figure represent at least three independent
repeats.
(E) HAC1 RNA cleavage reactions with different
concentrations of various competitor RNAs
(representative reactions shown Figures S1G
and S1H).
(F) RIDD reactions are competed by RIDD sub-
strate RNA but not by HAC1 RNA (representative
reactions shown in Figures S1K and S1L).
(G) RIDD RNA cleavage competition reactions
performed under single turnover conditions
(Figure S2A) (representative reactions shown in
Figure S2B).XBP1/HAC1 RNA Cleavage Is Not Competed by RIDD
Substrates
To determine the molecular relationship between IRE1-medi-
ated cleavage of HAC1 and RIDD substrate RNAs, we per-
formed in vitro yIre1 RNase reactions with radiolabeled RNA
substrates in the presence of unlabeled (cold) RNA competi-
tors. If IRE1 uses the same active site for binding and cleavage
of both HAC1 and RIDD substrates, then both substrate RNAs
should compete for the same active site. However, if the active
sites are different, then HAC1 and RIDD RNA substrates
should not compete equally well under single turnover condi-
tions (Figure S1F). Cleavage of radiolabeled HAC1 RNA
decreased upon addition of increasing amounts of cold
HAC1 RNA, resulting in the accumulation of uncleaved radiola-
beled HAC1 RNA (Figures 1C–1E and S1G). The addition ofCell Reports 9, 850–858,cold XBP1 RNA also resulted in
decreased cleavage of radiolabeled
HAC1 RNA (Figures 1C–1E, and S1H).
Conversely, cold HAC1 also inhibited
cleavage of radiolabeled XBP1 (Figures
S1I and S1J). In contrast, addition of
cold INSULIN RNA at a high concentra-
tion (15 mM) did not notably affect the
cleavage of radiolabeled HAC1 RNA
(Figures 1C–1E and S1G). The converse
was also true: cleavage of radiolabeled
INSULIN RNA was inhibited by excess
amounts of cold INSULIN RNA but not
HAC1 RNA (Figures 1F and S1K).Furthermore, the cleavage of another RIDD substrate, BLOS1
RNA, was also inhibited by excess amounts of cold INSULIN
RNA (Figures 1F and S1L). During these competition
experiments, we noted that overall RIDD cleavage (either
with INSULIN or BLOS1 RNA) was rather less effective than
HAC1 or XBP1 RNA cleavage, suggesting that 3 mM yIre1
might not truly represent a single turnover condition for RIDD
cleavage. In fact, further experiments revealed that RIDD
reaction was saturated at 10 mM (Figure S2A). Thus, we per-
formed a similar set of RIDD competition at yIre1 concentra-
tions (15 mM) and found essentially the same results: cold
INSULIN but not HAC RNA competed with INSULIN cleavage
(Figures 1G and S2B). Taken altogether, these results suggest
that Ire1 cleaves HAC1 or RIDD RNA substrates using two
distinctive binding and/or catalytic sites.November 6, 2014 ª2014 The Authors 851
Figure 2. RIDD Requires the Nucleotide
Binding in the IRE1 Kinase Domain and Ex-
hibits Noncompetitive Inhibition with the
HAC1 RNA Cleavage Reaction
(A and B) Lineweaver-Burk plots of steady-state
yIre1 RNase reactions cleaving radiolabeled HAC1
containing no competitor (black), cold HAC1 (blue)
(A), or INSULIN RNA (red) (B). Error bars represent
three independent repeats (representative re-
actions shown in Figure S2E).
(C and D) RNA cleavage reactions of HAC1 (C) or
BLOS1 (D) RNA were performed with WT yIre1 or
D828A yIre1 (1 mM) for 15 min. RNA cleavage frag-
ments are indicated schematically.
(E) L745G yIre1 (1 mM) cleaves BLOS1 and HAC1
RNA in the presence of ADP or the nonhydrolyzable
ATP homolog 1NM-PP1 (20 mM).To determine whether these two forms can interchange, we
performed competition assays under steady-state conditions
using a decreased amount of protein (0.1 mM). The addition of
0.15, 0.3, and 1.5 mM cold HAC1 RNA to radiolabeled HAC1
RNA resulted in dose-dependent inhibition (Figure S2C). In Line-
weaver-Burk plot, we found that inhibition of radiolabeled HAC1
cleavage by cold HAC1 RNA showed competitive inhibition (Fig-
ures 2A and S2E). In contrast, we found that cold INSULIN in-
hibited the cleavage of radiolabeled HAC1 RNA (Figure S2D) in
the mode of noncompetitive inhibition (Figures 2B and S2E),
providing additional support that Ire1 has two distinct RNA sub-
strate binding and/or catalytic sites for cleaving HAC1 or RIDD
RNA substrates.
IRE1 Kinase Domain Requirements for RIDD
Results of competition experiments were unexpected and
raised a question of what conferred the mechanistic differences
of Ire1 cleaving XBP1/HAC1 or RIDD RNAs. Nucleotide binding
is known to play a key role in activating Ire1 RNase for XBP1/
HAC1 RNA cleavage (Lee et al., 2008). D828 in yIre1 is impor-
tant for coordinating magnesium (Mg2+) in the active site, and a
D828A yIre1 mutant is still able to bind ATP but is unable
to transfer phosphates (Chawla et al., 2011). In agreement
with previous work, WT and D828A yIre1 were able to cleave
HAC1 RNA (Figure 2C) (Chawla et al., 2011). Similarly, we found
that WT and D828A yIre1 were also able to cleave BLOS1 RNA
(Figure 2D). The importance of nucleotide binding for both
HAC1 and RIDD RNA cleavage was further confirmed by the
use of the L745G mutant yIre1, which has an altered nucleotide
binding pocket capable of binding the nonhydrolyzable ATP ho-852 Cell Reports 9, 850–858, November 6, 2014 ª2014 The Authorsmolog 1NM-PP1 (Papa et al., 2003).
Upon binding to 1NM-PP1, L745G yIre1
was capable of cleaving both HAC1
and BLOS1 RNA (Figure 2E), indicating
that binding in the nucleotide pocket is
sufficient for RIDD activation. Taken alto-
gether, the importance of the nucleotide
binding in the Ire1 kinase domain is the
same for cleavage of both HAC1 and
RIDD RNA and thus is unlikely to be thekey determinant that differentiates HAC1 and RIDD substrate
cleavage.
Differences in IRE1 Cooperativity Distinguish between
XBP1/HAC1 and RIDD Substrate RNA Cleavage
The kinase domain of Ire1 is necessary for oligomer formation,
an important step leading to XBP1/HAC1 splicing, and the
oligomer of Ire1 can be monitored by foci formation using
IRE1-GFP (Arago´n et al., 2009; Ishiwata-Kimata et al., 2013;
Korennykh et al., 2009; Li et al., 2010). At 1 hr after treating
HEK293 cells with thapsigargin (Tg), a well-characterized
UPR-activating drug that disrupts calcium levels in the ER,
the IRE1-GFP foci were detected (Figure S3A). These foci
became larger at 4 hr and then had dispersed by 8 hr (Fig-
ure S3A). Samples collected at the same time showed XBP1
splicing detectable within 1 hr of treatment and continuing for
4 hr before starting to decline (Figure S3B) as reported previ-
ously (Li et al., 2010). In contrast, significant levels of RIDD ac-
tivity, which was calculated as a percentage of substrates
cleaved (BLOS1 and SCARA3), did not appear until 2 hr after
UPR induction and continued to increase throughout the time
course (Figure S3B). At the 8 hr time point, RIDD activity was
at its highest, and no IRE1-GFP foci were present (Figures
S3A and S3B). Our finding in vitro that both XBP1 and RIDD
substrate RNA cleavage occurred within a minute of incubation
revealed that IRE1 was capable of cleaving either substrate
with similar kinetics (Figures 1A, 1B, and S1C). The differences
observed here in vivo might come from differential availabilities
of these RNA substrates. However, both XBP1 and BLOS1
mRNA were associated with the ER membrane even prior to
ER stress induction (Figure S3C). This suggests that a regula-
tory step(s) beyond RNA localization is unlikely to be respon-
sible for generating the differences in activation kinetics of
XBP1 splicing and RIDD in vivo. Although factors other than
the RNA cleavage by IRE1, including the ligation step for
XBP1 splicing or degradation of the cleaved fragments for
RIDD, affect the appearance of the spliced form of XBP1 or
overall levels of RIDD substrate mRNA in cells, these findings
hinted that formation of IRE1 higher ordered structures, which
correlate with XBP1 mRNA splicing, might not be necessary
for RIDD activity, and warranted for further examination.
To investigate contributions of higher order structure of Ire1 in
the XBP1 or RIDD RNA cleavage, we tested cooperativity of Ire1
and determined the Hill coefficient to be 2.13 ± 0.38 for yIre1-
cleaving HAC1 RNA (Figures 3A and S3D) and similarly the Hill
coefficient for hIre1 cleaving XBP1 RNA to be 3.07 ± 0.65 (Fig-
ures 3A and S3E), indicating that Ire1 RNase for HAC1 or XBP1
consists of Ire1 complex with the presence of cooperativity
(Korennykh et al., 2009). In contrast, the Hill coefficients for the
RIDD reactions were 1.15 ± 0.19 for yIre1 and 1.10 ± 0.29 for
hIre1, indicating essentially no cooperativity (Figures 3A, S3D,
and S3E). In addition, we found that the Hill coefficient value
for a HAC1 substrate with only one cleavage due to a mutation
at the 30 splice site (Figure S3F) was similar to that for the WT
HAC1 RNA, revealing that the number of cleavage sites does
not matter for cooperativity.
In addition to Hill coefficients, we also performed transcom-
plementation assays using WT and H1061N (a catalytically
inactive mutant) yIre1. Previous studies found that H1061 par-
ticipates in the proton relay mechanism necessary for cleaving
HAC1 RNA (Korennykh et al., 2011). A mutation at this site pre-
vents cleavage of HAC1 RNA without disrupting yIre1 oligomer
formation (Figures S3G and S3H) (Korennykh et al., 2011).
Furthermore, we found that H1061N yIre1 was also inactive
for RIDD substrate cleavage (Figure S3G). In the transcomple-
mentation assay, we kept the concentration of WT yIre1 con-
stant at 0.083 mM where yIre1 remained as a monomer upon
performing the previously reported oligomerization assay (Fig-
ure S3H) (Korennykh et al., 2011). Furthermore, WT yIre1
showed very little cleavage activity for either HAC1 or RIDD
substrates (Figure 3B, lanes 1 and 7). As increasing amounts
of H1061N yIre1 were added, the heterocomplexes became
active for HAC1 cleavage (Figure 3B, lanes 2–5), consistent
as previously reported (Korennykh et al., 2011). However,
once the concentration of H1061N yIre1 far exceeded that
of WT yIre1, HAC1 RNA cleavage became inactive (Figure 3B,
lane 6). In contrast, RIDD RNA cleavage was restored
when H1061N yIre1 was added at an equal or 2-fold higher
concentration of WT yIre1 (Figure 3B, lanes 7–9), but higher
levels of H1061N yIre1 inhibited RIDD cleavage (Figure 3B,
lanes 10–12).
Oligomerization State of IRE1 Can Distinguish between
HAC1 and RIDD Substrate RNA Cleavage
These observations also provided a prediction that disruption
of the interfaces within the yeast Ire1 oligomers has little
impact on RIDD cleavage. To test this idea, we prepared three
mutant forms of yeast Ire1 carrying a mutation at one of theCthree interfaces: IF1c Glu 988, IF2c Arg 1087, and IF3c Arg
899, generating E988Q, R1087D, and R899A yIre1, respec-
tively (Korennykh et al., 2009) (Figure 3C). All three yIre1 inter-
face mutants did not generate oligomers based on the
oligomerization assay (Figure S3H) (Korennykh et al., 2009).
In agreement with previous reports (Korennykh et al., 2009;
Lee et al., 2008), we found that alterations in any of these res-
idues inactivated HAC1 RNA cleavage (Figure 3D). In contrast,
IF2c-R1087D yIre1 remained active for RIDD at the rate similar
to WT yIre1 (Figures 3E and 3F), whereas E988Q and R899A
yIre1 did not show RIDD cleavage (Figures 3D and 3E).
R1087 is localized between the two RNase interface in the
oligomer (Figure 3C), and the ability of R1087D yIre1 to retain
the cleavage of RIDD RNA, but not that of HAC1 RNA, pro-
vided a further support for the different nature of RIDD RNase
reactions.
Curiously, we found that both E988Q yIre1 and R1087D yIre1
were active kinases able to undergo autophosphorylation
(Figure S3I) (Chawla et al., 2011; Han et al., 2009; Lee et al.,
2008). E988Q yIre1 is an inactive RNase for both HAC1 RNA
and RIDD, suggesting that activation of the kinase domain alone
is not sufficient to generate an active Ire1 RNase. This is a
notable result as the current model proposes that Ire1 initially
forms ‘‘face-to-face’’ dimers where the nucleotide binding
pockets are facing each other within Ire1 dimer (Figure S4A),
and structural studies reveal that the two RNase domains are
not in close proximity (Figure S4A) (Ali et al., 2011). Presumably,
formation of dimers in a ‘‘back-to-back’’ form where the nucle-
otide binding pockets are facing away from each other brings
two RNase domains together to create a catalytically active
RNase (Lee et al., 2008). The back-to-back dimer is present in
the crystalized oligomer that corresponds to the IF1c interface
(compare Figure S4A [back-to-back dimer] with Figure 3C
[IF1c]) (Korennykh et al., 2009). Recently, quercetin (Q) has
been shown to induce the formation of yIre1 back-to-back di-
mers by binding to the Q site, an interface between the kinase
and RNase domain (Figure S4A) (Wiseman et al., 2010). Q bind-
ing can occur independent of Ire1 kinase domain and activates
Ire1 RNase for cleavage of HAC1 RNA (Figures 4A and S4B)
(Wiseman et al., 2010). Similarly, we found that the binding of
Q to Ire1 was sufficient to promote cleavage of RIDD substrate
RNA (Figures 4A and S4B). Given that RIDD does not require
oligomer formation (Figures 3A and 3D–3F), these results sug-
gest that the Ire1 back-to-back dimer itself is sufficient for
RIDD cleavage.
To further understand the mechanistic differences in Ire1 for
HAC1 RNA and RIDD cleavage, we examined the effect of the
Ire1 RNase specific inhibitor STF-083010 (STF) on yIre1 acti-
vated by ADP or Q. We found that HAC1 cleavage by ADP- or
Q-activated yIre1 was effectively inhibited by STF, both with an
IC50 around 30 mM (Figure 4B) (Papandreou et al., 2011). STF
also potently inhibited cleavage of RIDD substrates when yIre1
was activated by ADP (Figures 4B [orange closed circles] and
4D). In contrast, however, STF was not able to inhibit Q-induced
RIDD as effectively as ADP activated RIDD even at higher con-
centration (Figure 4B [compare open with closed orange circles]
and 4D). Structural comparisons of ADP-bound Ire1 (Figure 4C,
in purple) (Korennykh et al., 2009) and Q-bound Ire1 (in green)ell Reports 9, 850–858, November 6, 2014 ª2014 The Authors 853
Figure 3. Cleavage of RIDD Substrate RNA Does Not Require Cooperative IRE1 Oligomerization
(A) Cooperative activation modes were observed for yIre1 and hIre1 cleaving HAC1 and XBP1 RNA, respectively, but not for cleaving INSULIN RNA. Cooperative
Hill coefficients for yIre1/HAC1 (2.13 ± 0.38) and hIre1/XBP1 (3.07 ± 0.65) were found, while noncooperative values were found for yIre1/INSULIN (1.15 ± 0.19)
and hIre1/INSULIN (1.10 ± 0.29). We interpret a noncooperative Hill coefficient of ‘‘1’’ as Ire1 acting as a dimer since unassociated, monomeric Ire1 is inactive (Lee
et al., 2008), and the minimal active unit for Ire1 is a dimer (Figure S4A). All error bars in this figure were calculated from at least three independent experiments
(representative reactions shown in Figures S3D and S3E).
(B) Transcomplementation assay between WT yIre1 and H1061N yIre1. WT yIre1 was kept at a concentration below the oligomerization threshold (0.083 mM)
(Figure S3H) and inactive. Increasing amounts of catalytically inactive H1061N yIre1 atmolar ratios from 1:0–1:12 ([WT]:[H1061N]) were added. A schematic of the
experiment is shown in the top panel.
(legend continued on next page)
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Figure 4. IRE1 RIDD Contributes to Cell
Death
(A) Cleavage of HAC1 (left) or BLOS1 RNA (right)
with WT yIre1 (1 mM) activated with ADP (2 mM)
(closed circle) or Q (100 mM) (open circle). Error
bars in this figure were calculated from at least
three independent experiments.
(B) Nuclease reactions were performed with vary-
ing concentrations of STF-083010 (STF), an inhib-
itor, on WT yIre1 (1 mM) activated with either ADP
(2 mM) (closed circles) or Q (100 mM) (open circles).
(C) The core RNase catalytic center between oli-
gomerized Ire1, the ADP activated form ‘‘ADP’’
(purple) (Korennykh et al., 2009) and Q activated
‘‘Q’’ (green) yIre1 (Wiseman et al., 2010) is similar at
the molecular level, except for the spatial orienta-
tion of the R1039 residue. The right panel shows
structure predictions of R1039A yIre1 activated by
ADP (purple) or Q (green).
(D and E) HAC1 or RIDD cleavage by (D) WT yIre1
(1 mM) or (E) R1039A yIRE1 was activated by Q
(100 mM) or ADP (2 mM) with and without STF
(60 mM) for 30 min.
(F) STF inhibited XBP1mRNA splicing but not RIDD
for Q-activated hybrid IRE1 (hyIRE1) in vivo with or
without STF (60 mM) for 2 hr.
(G and H) Preferential inhibition of XBP1 splicing
but not RIDD in hyIRE1 induced (G) cell death and
(H) apoptosis.(Wiseman et al., 2010) revealed that the core catalytic residues,
including H1061 and Y1043, remain unchanged but that the
orientation of R1039 side chain became significantly different
(Figure 4C, left). R1039 has been identified as a HAC1 RNA
binding residue (Korennykh et al., 2011). In fact, we found that
altering R1039 to Ala in yIre1 diminished RNase activity for
HAC1 RNA as anticipated, but R1039A yIre1 remained active
for the cleavage ofBLOS1RNAsimilarly toWTyIre1 (Figure S4C),
revealing that RIDD cleavage reaction does not engage R1039
residue as it does for HAC1 RNA cleavage. Furthermore,
R1039A yIre1 became insensitive to STF for the cleavage of(C) Three interfaces in yIre1 oligomer (IF1c E988, IF2c R1087, and IF3c R899) previously identified from X-ray
2009). One monomer of IRE1 (red) can contact three different monomers (orange, blue, green) within a tetra
IF3c, respectively (bottom panel). Locations of IF1c (E988), IF2c (R1087), and IF3c (R899) interactions are sh
(D) Nuclease reactions were performed with either WT yIre1 or interface mutants IF1c E988Q, IF2c R1087D,
(E and F) Time course of BLOS1 RNA cleavage reaction with WT yIre1 or yIre1 interface mutants (E) and the q
WT and IF2c yIre1.
Cell Reports 9, 850–858,both HAC1 and BLOS1 RNA (Figures 4E
and S4D). Taken together, these observa-
tions suggest that R1039 residue of yIre1
is involved in HAC1 RNA cleavage but
does not play a significant role in the
RIDD.
Differential Activation of IRE1
Determines Cell Fate Decisions
Preferential inhibition of Q-activated Ire1
cleavage of HAC1 RNA but not RIDD sub-
strates would provide a useful tool todissect functional consequences of these two activities of Ire1.
Q was not effectively taken up by yeast cells (Wiseman et al.,
2010), which precluded the use of yeast for our analyses.
Elegantly, a previous report demonstrated that a chimeric hybrid
IRE1 (hyIRE1) where a human luminal domain was fused with the
yeast cytosolic domain could be activated by Qwhen expressed
in ire1 knockout mouse embryonic fibroblasts (MEFs) (Wiseman
et al., 2010). Using hyIRE1, we confirmed that hyIRE1 was not
activated when Tg was used to induce ER stress, as reported
previously (Figure 4F; Tg and Tg + STF). In contrast, incubation
of hyIRE1 cells with Q activated hyIRE1 RNase for both XBP1crystallographic structure studies (Korennykh et al.,
mer, leading to the three interfaces, IF1c, IF2c, and
own (arrows).
and IF3c R899A yIre1 (1 mM) for 10 min.
uantitation (F) of BLOS1 RNA cleavage activities for
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RNA splicing (Q, blue bar) and RIDD cleavage (Figure 4F; Q,
orange bar). Furthermore, STF treatment inhibited XBP1 splicing
(Figure 4F; Q + STF, blue bar), whereas cleavage of BLOS1RIDD
RNA occurred normally even in the presence of STF (Figure 4F;
Q + STF, orange bar), recapitulating our in vitro results (Figures
4B and 4D).
Thus, we tested the functional consequence of XBP1 mRNA
splicing inhibition, but leaving RIDD intact by examining the
extent of cell death. Upon treatment of hyIRE1 cells with Q and
STF, numbers of cells stained with Crystal violet were reduced
(Figure 4G), and PARP cleavage was elevated (Figure 4H)
when compared with those treated with Q alone, revealing that
RIDD activation without XBP1 splicing induces more predomi-
nant cell death. Similarly, we also tested the effect of STF on
Q-activated mammalian cells carrying the endogenous WT
IRE1 (Figures S4F–S4K), as we found that Q was able to activate
hIre1for both XBP1 RNA and BLOS1 RNA cleavage in vitro (Fig-
ure S4E). Preferential inhibition of XBP1 splicing but not RIDD
brought by Q and STF resulted in more diminish numbers of
crystal violet stained cells and increased PARP cleavage, in
comparison to both XBP1 splicing and RIDD activation in
Q-treated cells (Figures S4I and S4J). Finally, experiments with
ire1 knockout MEFs conferred that the increase in apoptotic
events observed in WT MEFs was an IRE1-dependent event
(Figures S4K–S4M). Altogether, these findings, consistent
with previous studies (Han et al., 2009; Upton et al., 2012), indi-
cate that activation of RIDD without XBP1 RNA promotes cell
death.
DISCUSSION
Our data suggest that activated IRE1 RNase has different mech-
anisms for cleaving XBP1/HAC1 RNA or RIDD substrates. Spe-
cifically, a catalytically active IRE1 unit engaged in HAC1 or
XBP1 mRNA splicing is generated within the IRE1 oligomer,
while IRE1 engaged in RIDD resides within an IRE1 monomer/
dimer. An active catalytic core for XBP1/HAC1 mRNA cleavage
is unlikely to consist of all subunits within the IRE1 oligomer,
but rather, oligomerization will lead to formation of the catalyti-
cally active pocket by establishing a specific orientation of cata-
lytic residues. The structural conformation of the RNA binding
and/or RNase catalytic residues within the catalytic core unit
must differ such that HAC1 or XBP1 RNA cannot compete the
cleavage reaction of RIDD substrates and vice versa under sin-
gle turnover conditions (Figures 1C–1G). Consistent with this
idea, the Hill coefficient for IRE1 engaged in HAC1 or XBP1
RNA cleavage showed cooperativity among IRE1 subunits, while
IRE1 engaged in RIDD cleavage displayed no significant cooper-
ativity and may not form higher order structures as it does not
require the IF2c (R1087) interface (Figures 3D–3F). It is possible,
however, that IRE1 engaged in RIDD could also exist within an
oligomer without any cooperative impact from other IRE1 sub-
units in the complex.
Structural and biochemical studies have revealed that the
H1061 residue of yeast IRE1 plays a critical role in catalysis of
HAC1 cleavage (Korennykh et al., 2011). Similarly, we found
that H1061 was also important for RIDD substrate cleavage (Fig-
ures 3B and S3G). Previous studies have also demonstrated that856 Cell Reports 9, 850–858, November 6, 2014 ª2014 The AuthorsR1039 residue is involved in binding to HAC1 RNA (Korennykh
et al., 2011). Mutation of R1039 to Alanine did not affect ability
of yIre1 to cleave RIDD substrate, while it decreased that of
HAC1 RNA (Figure S4C). Curiously, comparisons of Ire1 struc-
ture bound to Q highlight a difference in the spatial orientation
of R1039 residue (Figure 4C). The ability of an IRE1 RNase inhib-
itor STF-083010 (STF) to inhibit HAC1 RNA cleavage occurred
regardless of the side-chain orientation of R1039, while the
cleavage of BLOS1 RNA by Q-induced yIre1, but not by ADP-
induced yIre1, was no longer inhibited by STF-083010 (Figures
4B and 4D). Together with the noncompetitive inhibition between
RIDD and HAC1 substrates under steady-state competition ex-
periments, these results point that binding sites for XBP1/HAC1
RNA and RIDD substrate may differ, while both reactions share a
catalytic site, including H1061 residue. Future work will require
understanding of how RIDD substrates bind to IRE1 at the mo-
lecular level.
Notably, our model for IRE1 activation is different from what
has previously been proposed (Han et al., 2009) where higher or-
dered structures were assigned to the RIDD active form of IRE1.
Experiments reported by Han et al. (2009) utilized murine I642G
IRE1, a homolog of L745G yeast IRE1, that binds to a modified
nucleotide, 1NM-PP1. Upon expressing I642G IRE1 in INS-1
cells, the addition of 1NM-PP1 (without ER stress induction) acti-
vated XBP1mRNA splicing but not RIDD. In INS-1 cells express-
ing WT IRE1, instead of I642G IRE1, both XBP1 mRNA splicing
and RIDD occurred. Since I642G IRE1 does not autophosphory-
late, it was concluded that I642G hIRE1 was unable to perform
RIDD due to the lack of both phosphorylation and its accompa-
nying oligomerization. However, we found that L745G yIre1 it-
self, a yeast homolog of I642G IRE1, was active for RIDD
in vitro upon binding to 1NM-PP1 (Figure 2E), revealing that a
lack of RIDD may not be an intrinsic property of L745G (or
I642G) IRE1. Further studies have also reported that I642G
IRE1 is active for RIDD upon addition of 1NM-PP1 (Upton
et al., 2012) andwith ER stress when introduced into ire1/ cells
(Hollien et al., 2009). These experiments suggest that, in addition
to the occupancy of the kinase nucleotide-binding pocket, the
ER stress-induced conformational change of the cytosolic
portion of IRE1 containing both kinase and RNase domains
holds a key to activation of I642G IRE1. The importance of the
conformational change(s) through the ER luminal, transmem-
brane, and linker domains for activation of IRE1 RNase has pre-
viously been described (Credle et al., 2005; Korennykh et al.,
2009; Volmer et al., 2013; Zhou et al., 2006). Such conforma-
tional changes may also trigger oligomerization and ultimately
full activation of IRE1. In vitro, L745G yIre1 binding to 1NM-
PP1 caused a mobility shift to heavier fractions on a density
gradient sedimentation assay similar to ADP-bound WT yIre1
(Papa et al., 2003), revealing that L745G yIre1 is capable of form-
ing a higher order structure similar to WT yIre1 without the ER
luminal domain.
Additionally, in these previous experiments (Han et al., 2009),
I642G IRE1 was introduced into INS-1 cells that express the
endogenous WT IRE1. Here, we demonstrated that even a
catalytically inactive H1061N yIre1 could reconstitute WT
yIRE1 present below its active concentration. Importantly, we
demonstrate that at higher molar ratios of WT to mutant IRE1,
HAC1 cleavage but not RIDD can be reconstituted (Figure 3B),
suggesting that overexpressing mutant IRE1 may favor XBP1
splicing over RIDD. Finally, our results revealed that the HAC1
RNA cleavage activity of yIre1 is intrinsically more active than
RIDD (Figures S1F and S2A), and thus, comparisons of activities
between different forms of IRE1 should be performed carefully.
Future work will require more understanding of I642G/L745G
mutant IRE1.
This report shows that RIDD can occur in yeast, S. cerevisiae.
We have previously reported that the only RNA cleaved by IRE1
in yeast is HAC1 RNA (Niwa et al., 2005). However, the yeast re-
combinant IRE1 used in the previous study differed slightly from
the one used in this study, where the linker domain was short-
ened in the yIre1 used for this study. We and others have noted
that yIre1 with the full-length linker domain is less active for
HAC1 RNA cleavage (Korennykh et al., 2009). In addition, yIre1
with the full-length linker domain does not show significant
RIDD cleavage activity. The molecular reasons for this observa-
tion are not clear, but it is in agreement with recent studies high-
lighting the importance of the linker region (Volmer et al., 2013).
Since IRE1 exhibits dual RNase activities, this calls into ques-
tion the role of RIDD in vivo. Previously, contributions of RIDD
versusXBP1mRNA splicing in vivowere assessed by comparing
ire1 knockout and xbp1 knockout cells with a rationale that sub-
tracting the XBP1 contribution in xbp1 knockout cells would
allow assessment of RIDD functions (Hur et al., 2012). However,
since both unspliced and spliced XBP1 mRNA is not present in
xbp1 knockout cells, results from this approach also include
contributions from an absent unspliced XBP1 protein and
changes in transcription due to a lack of XBP1, not simply from
RIDD activation alone. Furthermore, while no additional IRE1
splicing substrate mRNA beyond XBP1 has been identified,
splicing of such RNA would take place normally in xbp1
knockout cells. Initially, activation of the IRE1 branch of the
UPR was thought to be protective by virtue of XBP1 splicing
(Lin et al., 2007). However, our finding that RIDD promotes cell
death highlights the importance of re-evaluating the functional
significance of IRE1 activation. In S. pombe, where either
HAC1 or XBP1 is absent, making RIDD the sole function for
IRE1, a recent report revealed that IRE1 cleaves KAR2/BiP, a ho-
molog of GRP78, within its 30 UTR as a RIDD substrate (Kimmig
et al., 2012), resulting in increased translation, rather than degra-
dation. In addition, the kinetics or intensity of RIDD versus XBP1/
HAC1 splicingmay differ depending on the cell or tissue type and
the nature of the ER stress and ultimately may change the overall
outcomes. Thus, careful evaluation of both the mechanistic
and functional consequences between RIDD activation versus
XBP1/HAC1 splicing will provide a greater understanding of
how ER stress affects cell physiology and also provide rationales
for development of drugs and more effective treatment strate-
gies for ER stress-related diseases.EXPERIMENTAL PROCEDURES
In vitro transcription of IRE1 substrates, protein purification, and in vitro
nuclease assay; determination of Hill coefficient; and determination of XBP1
splicing and RIDD in vivo are described in the Supplemental Experimental
Procedures.CCompetition Assays and Michaelis-Menten Kinetics
For single-turnover conditions, reactions were set up by incubating 3 mM of
yIre1 (Figures 1E and 1F) or 15 mM yIre1 (Figure 1G) with buffer followed by
addition of unlabeled (cold) RNA at the indicated concentrations. To this reac-
tion mixture, 0.5 nM (Figures 1E and 1F) or 0.25 nM (Figure 1G) of radiolabeled
RNA substrate were added and incubated at 30C for 5 min. Reactions were
then started upon addition of 2 mM ADP and stopped at the indicated times,
as described in in vitro nuclease assay (Supplemental Experimental Proce-
dures). For steady-state competition, reactions were performed similarly,
except that 0.1 mM yIre1 was used and the concentration of radiolabeled
RNA substrate was varied from 0.05–1.50 nM, as indicated and competed
with 1.5 mM cold RNA. Samples were analyzed on a 6% urea gel, and molar
values for uncleaved and cleaved products were calculated as described
above. Velocity (nM/s) was calculated with the slope of the linear regression
line of the graph plotting cleaved substrate (nM) over time (s). To generate
the Lineweaver-Burk plots, the reciprocal of substrate concentration was
plotted against the reciprocal of the velocity. Linear regression trend lines
were then generated and graphed in Figures 2A and 2B.
trans-Complementation Assay
For transcomplementation assays, in vitro nuclease reactions were set up with
nuclease reaction buffer, 2mMADP, and 0.083 mMofWT yIre1. At this concen-
tration of WT yIre1, efficient cleavage of eitherHAC1 or RIDD RNA did not take
place (Figure 3B, lanes 1 and 7). H1061N yIre1 was added to the reaction at
molar ratios of 1:1, 1:2, 1:4, 1:6, or 1:12 ([WT]:[H1061N]). Reactions were
started upon addition of 0.5 nM radiolabeled substrate and proceeded for
10 min at 30C.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2014.09.016.
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